Prostate cancer is one of the leading cancers in men, with a 5-year survival rate of 64% in India alone. It commonly occurs in males aged 65 and above. However, there has been a rise in prostate cancer cases among the younger population in recent times.
Experts warn against delay in diagnosis and treatment, given that it can prove fatal and untreatable. Most often , the symptoms of prostate cancer are either ignored or neglected, leading to advanced stages of the cancer. That said, take a note of all the early signs of prostate cancer and do not mistake it for a benign illness.
The Goodbody Health Group Inc. is listed on the Canadian Securities Exchange (CSE), the Aquis Stock Exchange – Growth Market (AQSE) Apex segment, OTC, and Frankfurt Stock Exchange (FSE), providing current and prospective shareholders with multiple platforms in which to buy and sell Goodbody Health Group Inc. stock under the EPIC codes: CSE: GDBY / AQSE: GDBY / FRA: 484 / OTC: GDBYF).